Patient Square Capital’s Compass Pathways CMPS Stock Holding History

Patient Square Capital’s Portfolio CMPS Stock Details CMPS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$13.1M	Buy	+1,056,269	New	+$14M	2.1%	11

Other funds holding CMPS

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Candriam SCA Strassen, Luxembourg, Luxembourg $22.5B AUM 50.38% 1-Year Est. Return

Jefferies Financial Group New York $13.5B AUM 36.68% 1-Year Est. Return

Axxion S.A. Grevenmacher, Luxembourg $1.52B AUM

CenterBook Partners Greenwich, Connecticut $2.18B AUM 12.5% 1-Year Est. Return

AdvisorShares Investments Bethesda, Maryland $796M AUM 17.24% 1-Year Est. Return

Hennion & Walsh Asset Management Parsippany, New Jersey $3.42B AUM 25.82% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return

Premier Fund Managers Guildford, United Kingdom $978M AUM 14.27% 1-Year Est. Return

Royce & Associates New York $11B AUM 39.4% 1-Year Est. Return

Patient Square Capital's CMPS Position: Q3 2026 in Review

Patient Square Capital opened a new position in Compass Pathways (CMPS) in Q3 2026: 1,056,269 shares worth $13.1M. The stake represents 2.1% of the portfolio and ranks #11 among its holdings.

119 funds tracked by Wall St. Rank hold CMPS as of Q3 2026.

Patient Square Capital held 1,056,269 shares of Compass Pathways worth $13.1M as of Q3 2026.
Compass Pathways was a new Patient Square Capital position in Q3 2026.
Compass Pathways made up 2.1% of Patient Square Capital's portfolio in Q3 2026, its #11 holding.
119 funds tracked by Wall St. Rank held Compass Pathways as of Q3 2026.

Based on Patient Square Capital's 13F filing for Q3 2026, filed 10 Nov 2026.